Universitätsspital Basel and SwissTPH
Welcome,         Profile    Billing    Logout  
 9 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Labhardt, Niklaus D
DO-REAL, NCT04238767: Dolutegravir in Real Life in Lesotho

Completed
N/A
1433
RoW
Dolutegravir
Swiss Tropical & Public Health Institute, SolidarMed, Ministry of Health, Lesotho, District Health Management Team of Butha-Buthe, Lesotho, District Health Management Team of Mokhotlong, Lesotho, University of Basel
HIV-1-infection
05/21
05/21
GIVE MOVE, NCT04233242: Genotype-Informed Versus Empiric Management of VirEmia

Completed
N/A
286
RoW
Clinical management informed by HIV-1 genotypic resistance testing
Swiss Tropical & Public Health Institute, University Hospital, Basel, Switzerland, University of Basel, SolidarMed, Partnerships for Health, Seboche Mission Hospital, Ifakara Health Institute, Baylor College of Medicine Children's Foundation
HIV-1-infection
03/23
07/23
VITAL, NCT04527874: Viral Load Triggered ART Care in Lesotho

Completed
N/A
5809
RoW
VITAL model, automated differentiated service delivery
Swiss Tropical & Public Health Institute
HIV Infections
08/24
08/24
ComBaCaL T2D, NCT05743387: Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho

Active, not recruiting
N/A
253
Europe, RoW
T2D care package, Referral to the responsible health facility
University Hospital, Basel, Switzerland, Swiss Agency for Development and Cooperation (SDC), World Diabetes Foundation (WDF), SolidarMed
Type 2 Diabetes Mellitus (T2D)
02/25
02/25
NCT05684055: "Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)

Active, not recruiting
N/A
1352
Europe, RoW
First-line antihypertensive single-pill combination (SPC), Standardized counselling and referral to the closest health facility
University Hospital, Basel, Switzerland, Swiss Agency for Development and Cooperation (SDC), World Diabetes Foundation (WDF)
Arterial Hypertension
06/25
06/25
SaDAPT, NCT05452616: Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

Active, not recruiting
N/A
611
RoW
ART first- Therapeutic use trial, TB results first- Therapeutic use trial
University Hospital, Basel, Switzerland, Swiss National Science Foundation, SolidarMed Lesotho, Kamuzu University of Health Sciences, Malawi, Swiss Tropical & Public Health Institute, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, London School of Hygiene and Tropical Medicine
Human Immunodeficiency Virus (HIV) Infection
12/24
12/24
ComBaCaL, NCT05596773: Community-Based Chronic Disease Care in Rural Lesotho

Recruiting
N/A
16000
Europe, RoW
University Hospital, Basel, Switzerland, Swiss Agency for Development and Cooperation (SDC), World Diabetes Foundation (WDF), SolidarMed
Non-communicable Diseases (NCDs)
12/25
12/25
Calmy, Alexandra AC
Shingr'HIV, NCT05575830: Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Recruiting
4
225
Europe
Recombinant Zoster Vaccine, (Shingrix® )
Calmy Alexandra
RZV Vaccine (Shingrix ®)
09/24
09/25
B-free, NCT06037564: Multistage Trial

Enrolling by invitation
4
210
Europe
DOR/DTG/3TC, Doravirine (Pifeltro®) + Dolutegravir/Lamivudine (Dovato®)
Insel Gruppe AG, University Hospital Bern, Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, University of Bern
HIV, Drug Resistance, Drug Drug Interaction
10/26
09/27
UNITY, NCT05597735: Assessment of the Efficacy and Safety of Tecovirimat in Patients with Monkeypox Virus Disease

Recruiting
3
150
Europe, RoW
Tecovirimat, Placebo
ANRS, Emerging Infectious Diseases, University Hospital, Geneva, Oswaldo Cruz Foundation, Fundacion Huesped, Buenos Aires, Argentina
Monkeypox, Mpox
03/25
08/26
CADOVID, NCT05305508: Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19.

Completed
2
74
Europe
Calcium Dobesilate, DOXIUM 500, OM Pharma, Mannitol, Placebo
Hervé SPECHBACH, OM Pharma SA
COVID-19 Virus Disease
11/23
02/24
OPTICOV, NCT05587894: OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

Recruiting
2
256
Europe
Paxlovid 5 days, Nirmatrevlir/ritonavir, Paxlovid 10 days, Veklury, remdesivir
ANRS, Emerging Infectious Diseases, University Hospital, Geneva
COVID-19, Immunodeficiency
03/25
05/25

Download Options